|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005290,
umls-concept:C0006142,
umls-concept:C0021017,
umls-concept:C0086418,
umls-concept:C0246415,
umls-concept:C0392762,
umls-concept:C0456387,
umls-concept:C0681842,
umls-concept:C0871261,
umls-concept:C0936012,
umls-concept:C1515670,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2003-8-12
|
|
pubmed:abstractText |
The relationship of intratumoral mRNA levels of class I and III beta-tubulin isotypes with clinical response to docetaxel has been studied in breast cancer patients. Experimental Design: Expression of class I and class III beta-tubulin mRNA levels was determined by a real-time PCR in breast cancer tissues obtained from 39 patients with locally advanced breast cancers (n = 26) or locally recurrent breast cancers (n = 13) before docetaxel treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Complementary,
http://linkedlifedata.com/resource/pubmed/chemical/DNA Primers,
http://linkedlifedata.com/resource/pubmed/chemical/RNA,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Taxoids,
http://linkedlifedata.com/resource/pubmed/chemical/Tubulin,
http://linkedlifedata.com/resource/pubmed/chemical/docetaxel
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2992-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12912947-Adult,
pubmed-meshheading:12912947-Aged,
pubmed-meshheading:12912947-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:12912947-Base Sequence,
pubmed-meshheading:12912947-Breast Neoplasms,
pubmed-meshheading:12912947-DNA, Complementary,
pubmed-meshheading:12912947-DNA Primers,
pubmed-meshheading:12912947-Female,
pubmed-meshheading:12912947-Humans,
pubmed-meshheading:12912947-Middle Aged,
pubmed-meshheading:12912947-Models, Genetic,
pubmed-meshheading:12912947-Molecular Sequence Data,
pubmed-meshheading:12912947-Polymerase Chain Reaction,
pubmed-meshheading:12912947-Postmenopause,
pubmed-meshheading:12912947-Premenopause,
pubmed-meshheading:12912947-RNA,
pubmed-meshheading:12912947-RNA, Messenger,
pubmed-meshheading:12912947-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:12912947-Sequence Homology, Nucleic Acid,
pubmed-meshheading:12912947-Taxoids,
pubmed-meshheading:12912947-Treatment Outcome,
pubmed-meshheading:12912947-Tubulin
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Prediction of response to docetaxel by quantitative analysis of class I and III beta-tubulin isotype mRNA expression in human breast cancers.
|
|
pubmed:affiliation |
Department of Surgical Oncology, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
